Researchers from the University of Illinois have identified a key process coordinating liver maturation and polyploidization, ...

Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (“Creative Medical”), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced an expanded agreement ...

Scientist Sarallah Rezazadeh from the Icahn School of Medicine explores the molecular mechanisms behind adult stem cells as ...

"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

Cynata Therapeutics (ASX:CYP) has had its induced pluripotent stem cell (iPSC) derived mesenchymal stem cell (MSCs) verified ...

Novel approach designed to offer a more personalized and effective treatment option for patients suffering from diabetes and ...

Technology Holdings, Inc. (NASDAQ:CELZ), a clinical-stage biotechnology firm, has announced a strategic collaboration with Greenstone Biosciences Inc. to utilize Artificial Intelligence (AI) in ...

The study, conducted by esteemed researchers, demonstrated that applying INDIBA's Proionic System at subthermal levels ...

You will be redirected to our submission process. Induced pluripotent stem cells (iPSCs) have emerged as a transformative force in the realms of regenerative medicine, disease modeling, and drug ...

This module will provide students with a comprehensive understanding of current developments in stem cell biology and regenerative medicine. Students will study stem cell biology and stem cell ...

The Global Stem Cell Therapy For Diabetes Related Conditions market industry is primarily driven by the continuous advancements in technology.